55.92
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DOCS Giù?
Forum
Previsione
Precedente Chiudi:
$56.95
Aprire:
$55.59
Volume 24 ore:
1.28M
Relative Volume:
0.50
Capitalizzazione di mercato:
$11.05B
Reddito:
$550.17M
Utile/perdita netta:
$201.35M
Rapporto P/E:
55.92
EPS:
1
Flusso di cassa netto:
$232.07M
1 W Prestazione:
-4.98%
1M Prestazione:
-7.46%
6M Prestazione:
+7.25%
1 anno Prestazione:
+88.92%
Doximity Inc Stock (DOCS) Company Profile
Nome
Doximity Inc
Settore
Industria
Telefono
(650) 549-4330
Indirizzo
500 THIRD STREET, SAN FRANCISCO
Confronta DOCS con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
DOCS
Doximity Inc
|
55.92 | 11.05B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
VEEV
Veeva Systems Inc
|
282.55 | 46.63B | 2.86B | 780.66M | 1.20B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
71.28 | 10.75B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
HQY
Healthequity Inc
|
104.76 | 9.65B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
38.93 | 7.12B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-06-02 | Aggiornamento | BTIG Research | Neutral → Buy |
2025-02-07 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
2025-02-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2024-12-20 | Iniziato | Stephens | Equal-Weight |
2024-12-04 | Iniziato | Mizuho | Neutral |
2024-11-15 | Iniziato | Goldman | Neutral |
2024-11-14 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
2024-11-13 | Downgrade | Canaccord Genuity | Buy → Hold |
2024-11-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
2024-11-08 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
2024-10-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
2024-08-09 | Aggiornamento | Needham | Hold → Buy |
2024-07-18 | Downgrade | Wells Fargo | Equal Weight → Underweight |
2024-04-25 | Aggiornamento | JP Morgan | Underweight → Neutral |
2024-02-26 | Iniziato | Leerink Partners | Market Perform |
2024-01-03 | Iniziato | Barclays | Equal Weight |
2024-01-02 | Aggiornamento | BofA Securities | Underperform → Neutral |
2023-08-09 | Downgrade | Guggenheim | Buy → Neutral |
2023-08-09 | Downgrade | Needham | Buy → Hold |
2023-08-03 | Downgrade | Piper Sandler | Overweight → Neutral |
2023-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2023-01-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
2022-10-31 | Iniziato | Wells Fargo | Overweight |
2022-10-24 | Iniziato | Evercore ISI | In-line |
2022-10-13 | Iniziato | BTIG Research | Neutral |
2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
2022-09-07 | Iniziato | Truist | Hold |
2022-08-05 | Downgrade | BofA Securities | Neutral → Underperform |
2022-07-28 | Iniziato | Berenberg | Buy |
2022-05-18 | Reiterato | BofA Securities | Neutral |
2022-05-18 | Reiterato | Goldman | Buy |
2022-05-18 | Reiterato | Guggenheim | Buy |
2022-05-18 | Reiterato | Jefferies | Buy |
2022-05-18 | Reiterato | Morgan Stanley | Equal-Weight |
2022-05-18 | Reiterato | Needham | Buy |
2022-04-07 | Iniziato | Guggenheim | Buy |
2022-04-04 | Iniziato | BofA Securities | Neutral |
2022-02-11 | Iniziato | Goldman | Buy |
2021-12-14 | Downgrade | JP Morgan | Neutral → Underweight |
2021-12-02 | Iniziato | Jefferies | Buy |
2021-11-17 | Iniziato | Robert W. Baird | Outperform |
2021-11-10 | Reiterato | Canaccord Genuity | Buy |
2021-11-10 | Reiterato | Goldman | Neutral |
2021-11-10 | Reiterato | Morgan Stanley | Equal-Weight |
2021-11-10 | Reiterato | Needham | Buy |
2021-11-10 | Reiterato | Piper Sandler | Overweight |
2021-08-26 | Downgrade | JP Morgan | Overweight → Neutral |
2021-07-19 | Iniziato | Canaccord Genuity | Buy |
2021-07-19 | Iniziato | Goldman | Neutral |
2021-07-19 | Iniziato | JP Morgan | Overweight |
2021-07-19 | Iniziato | Morgan Stanley | Equal-Weight |
2021-07-19 | Iniziato | Piper Sandler | Overweight |
2021-07-19 | Iniziato | Raymond James | Outperform |
2021-07-19 | Iniziato | SVB Leerink | Outperform |
2021-07-19 | Iniziato | William Blair | Outperform |
Mostra tutto
Doximity Inc Borsa (DOCS) Ultime notizie
SG Americas Securities LLC Purchases Shares of 1,132,208 Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Sarasin & Partners LLP Buys New Shares in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity’s SWOT analysis: digital health leader’s stock faces macro headwinds - Investing.com India
Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Fort Washington Investment Advisors Inc. OH - MarketBeat
Harbor Capital Advisors Inc. Invests $1.28 Million in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
DOCS Boosts Client Retention via Workflow Integration and AI Tools - MSN
15,791 Shares in Doximity, Inc. (NASDAQ:DOCS) Purchased by Range Financial Group LLC - MarketBeat
Wellington Management Group LLP Purchases New Shares in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Shares Acquired by GAMMA Investing LLC - MarketBeat
Rhumbline Advisers Has $19.84 Million Stock Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity: Strong Growth but What's Next? - AOL.com
Doximity Declines 4.4% in a Month: How to Play the Stock Now? - MSN
Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm - Kilgore News Herald
Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Lmcg Investments LLC - MarketBeat
MRA Advisory Group Invests $505,000 in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
IMMINENT DOCS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Doximity, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Doximity, Inc. (NASDAQ:DOCS) Director Kira Scherer Wampler Sells 2,000 Shares - MarketBeat
Apella Capital LLC Purchases 9,719 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity Inc (DOCS) Shares Up 3.3% on Jun 5 - GuruFocus
Doximity Rides on Telehealth Demand: Will This Drive Sales Further? - MSN
6,106 Shares in Doximity, Inc. (NASDAQ:DOCS) Bought by B. Riley Wealth Advisors Inc. - MarketBeat
J2 Capital Management Inc Makes New $353,000 Investment in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity (NASDAQ:DOCS) Upgraded by BTIG Research to "Buy" Rating - MarketBeat
DOCS Q1 Earnings Call: Revenue Strong Sales Highlighting Growth in AI Tools and Client Portal Adoption - Yahoo Finance
SHAREHOLDER ALERT: Morris Kandinov Investigating DV, MANH, DOCS, and SEDG; Shareholders are Encouraged to Contact the Firm - GlobeNewswire Inc.
Doximity Inc (DOCS) Trading 3.38% Higher on Jun 3 - GuruFocus
Doximity (NASDAQ:DOCS) Rating Increased to Buy at BTIG Research - Defense World
Which Telehealth Stock Should You Be Targeting? - Schaeffer's Investment Research
“Demand…Will Continue to Rise”: Doximity Stock (NYSE:DOCS) Slips Despite Analyst Love - The Globe and Mail
BTIG Upgrades Doximity (DOCS) Stock to Buy from Neutral - MSN
Doximity Stock: A Deep Dive Into Analyst Perspectives (12 Ratings) - Benzinga
Doximity (DOCS) Receives Upgrade to 'Buy' with PT Maintained at $80 | DOCS Stock News - GuruFocus
Wells Fargo maintains Doximity stock rating, notes uncertain pharma ad market - Investing.com Canada
BTIG upgrades Doximity saying pullback on macro fears overdone - Investing.com Australia
BTIG upgrades Doximity saying pullback on macro fears overdone By Investing.com - Investing.com South Africa
Wells Fargo maintains Doximity stock rating, notes uncertain pharma ad market By Investing.com - Investing.com South Africa
Doximity Inc Azioni (DOCS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):